What are emerging therapies in regard to the treatment of pancreatic cancer?
The difficulty in discussing this topic is not because there are too few, but rather as there are so many creative experimental clinical trials which are occurring with newer agents and combinations against pancreatic cancer. However, it is important to note that many agents in that past have looked promising, only to show no advantage by the end of phase III clinical trials. These are experimental therapies, and can be highly risky. In listing some of the categories and individual agents below, this is in no way meant or to be considered as an endorsement of that category of drug or mode-of-action (or of a particular drug agent). These examples are given for education and discussion purposes only. The categories are representative of some of these newer agents and this listing is not meant to be exhaustive. As a better understanding is gained of the activity of the cell at the molecular level, more targeted approaches are being implemented to try and interrupt certain functions that a
